Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Vaccine-associated paralytic poliomyelitis in Brazil, 1989-1995

Dados Bibliográficos

ID14965915
AutoresLúcia Helena de Oliveira (Ministério da Saúde, autor correspondente), Cláudio José Struchiner (0000-0003-2114-847X, Ministério da Saúde)
Ano2000
Volume7
Fascículo4
Páginas219-224
Data de publicação2000-04-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoRevista Panamericana de Salud Pública (JOURNAL)
Identificadores do periódicoISSN: 1020-4989 • E-ISSN: 1680-5348
EditoraFapUNIFESP (SciELO) (PUBLISHER)
DOI10.1590/s1020-49892000000400002
PMID10846924
OpenAlexW2000892876
SCIELO_PIDS1020-49892000000400002
IdiomaEN
Citações recebidas2
Referências citadas3

At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. It is important for epidemiological surveillance and immunization programs to evaluate the epidemiological profile of cases of vaccine-associated paralytic poliomyelitis (VAPP) in order to establish criteria for case definition and vaccination strategies. To research VAPP in Brazil, 30 cases diagnosed and classified as such by the Ministry of Health between 1989 and 1995 were submitted to a descriptive study of clinical, laboratory, and epidemiological data. In addition, the risk of occurrence of VAPP was estimated in relation to determinants based on a cohort of 3,656 persons with acute flaccid paralysis. Among individuals who had received oral polio vaccine (OPV) from 4 to 40 days before the onset of paralysis, we found a relative risk of 8.88 (95% CI: 4.37-18.03) for VAPP as compared with persons who had not been vaccinated during the same time interval. For individuals who developed VAPP in the period following national vaccination days, the estimated relative risk was 2.94 (95% CI: 1.44-6.00). For the first dose of OPV administered to the general population the estimated risk was 1 case of VAPP for every 2.39 million doses; for total doses of OPV the risk was 1 case in 13.03 million doses. A major share of VAPP cases were related to children affected by prodromes (fever and gastrointestinal signs and/or symptoms), isolation of vaccine poliovirus type 2, paralysis of the lower limbs, and a mean age of 1 year

Cohort · Enterovirus · Environmental health · Etiology · Paralysis · Poliomyelitis · Poliovirus · Population · Vaccination · Virus · Medicine · Peripheral Neuropathies and Disorders · SARS-CoV-2 and COVID-19 Research · Viral Infections and Immunology Research · Epidemiology · Internal Medicine · Pediatrics · Surgery · Virology

  • Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en Colombia

    Open Access•Nelson Alvis-Guzman, Nelson Alvis et al.•Revista Panamericana de Salud…•2010

  • Ocorrência de poliomielite associada à vacina no Brasil, 1995 a 2001

    Open Access•Eduardo Souza Teixeira-Rocha, Eduardo Hage Carmo et al.•Revista Panamericana de Salud…•2005

  • Reporting vaccine-associated paralytic poliomyelitis

    Robert E Weibel, David E Benor•American Journal of Public Health•1996

  • A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases

    Roland W Sutter, Edward W Brink et al.•American Journal of Public Health•1989

Obras citantes distintas2
Citações por ano0,1
Intervalo de citações2005 - 2010 (6)
Velocidade de citaçãohistorical
Altamente citadoNão
Tipos de citaçãoNeutras: 1
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae